NeuroPace Statistics
Total Valuation
NeuroPace has a market cap or net worth of $397.23 million. The enterprise value is $406.42 million.
Important Dates
The last earnings date was Tuesday, March 4, 2025, after market close.
Earnings Date | Mar 4, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NeuroPace has 32.56 million shares outstanding. The number of shares has increased by 12.67% in one year.
Current Share Class | 32.56M |
Shares Outstanding | 32.56M |
Shares Change (YoY) | +12.67% |
Shares Change (QoQ) | +1.60% |
Owned by Insiders (%) | 3.57% |
Owned by Institutions (%) | 30.33% |
Float | 21.13M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 4.32 |
Forward PS | 4.03 |
PB Ratio | 44.58 |
P/TBV Ratio | 48.15 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 5.09 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.37, with a Debt / Equity ratio of 9.15.
Current Ratio | 5.37 |
Quick Ratio | 4.33 |
Debt / Equity | 9.15 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.46 |
Financial Efficiency
Return on equity (ROE) is -189.35% and return on invested capital (ROIC) is -15.53%.
Return on Equity (ROE) | -189.35% |
Return on Assets (ROA) | -13.39% |
Return on Invested Capital (ROIC) | -15.53% |
Return on Capital Employed (ROCE) | -27.26% |
Revenue Per Employee | $434,272 |
Profits Per Employee | -$147,505 |
Employee Count | 184 |
Asset Turnover | 0.79 |
Inventory Turnover | 1.69 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.17% in the last 52 weeks. The beta is 2.07, so NeuroPace's price volatility has been higher than the market average.
Beta (5Y) | 2.07 |
52-Week Price Change | -9.17% |
50-Day Moving Average | 12.63 |
200-Day Moving Average | 9.28 |
Relative Strength Index (RSI) | 50.10 |
Average Volume (20 Days) | 216,197 |
Short Selling Information
The latest short interest is 308,344, so 0.95% of the outstanding shares have been sold short.
Short Interest | 308,344 |
Short Previous Month | 245,600 |
Short % of Shares Out | 0.95% |
Short % of Float | 1.46% |
Short Ratio (days to cover) | 0.87 |
Income Statement
In the last 12 months, NeuroPace had revenue of $79.91 million and -$27.14 million in losses. Loss per share was -$0.93.
Revenue | 79.91M |
Gross Profit | 59.09M |
Operating Income | -21.67M |
Pretax Income | -31.51M |
Net Income | -27.14M |
EBITDA | -21.46M |
EBIT | -21.67M |
Loss Per Share | -$0.93 |
Full Income Statement Balance Sheet
The company has $52.76 million in cash and $73.34 million in debt, giving a net cash position of -$20.58 million or -$0.63 per share.
Cash & Cash Equivalents | 52.76M |
Total Debt | 73.34M |
Net Cash | -20.58M |
Net Cash Per Share | -$0.63 |
Equity (Book Value) | 8.01M |
Book Value Per Share | 0.27 |
Working Capital | 66.18M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$17.95 million and capital expenditures -$306,000, giving a free cash flow of -$18.26 million.
Operating Cash Flow | -17.95M |
Capital Expenditures | -306,000 |
Free Cash Flow | -18.26M |
FCF Per Share | -$0.56 |
Full Cash Flow Statement Margins
Gross margin is 73.94%, with operating and profit margins of -27.12% and -33.97%.
Gross Margin | 73.94% |
Operating Margin | -27.12% |
Pretax Margin | -33.97% |
Profit Margin | -33.97% |
EBITDA Margin | -26.86% |
EBIT Margin | -27.12% |
FCF Margin | n/a |
Dividends & Yields
NeuroPace does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -12.67% |
Shareholder Yield | n/a |
Earnings Yield | -7.03% |
FCF Yield | -4.73% |
Analyst Forecast
The average price target for NeuroPace is $14.83, which is 21.56% higher than the current price. The consensus rating is "Buy".
Price Target | $14.83 |
Price Target Difference | 21.56% |
Analyst Consensus | Buy |
Analyst Count | 6 |
Revenue Growth Forecast (5Y) | 25.28% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
NeuroPace has an Altman Z-Score of -4.96 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.96 |
Piotroski F-Score | 3 |